|
|
|
|
|
|
Cytomx Thera Cmn Stk (CTMX)
|
|
14.80 +0.41 (+2.85%)
|
6/23/2017 4:00pm
|
|
Open:
|
14.36
|
Pre. Close:
|
14.39
|
|
High:
|
14.97
|
Low:
|
14.12
|
|
Volume:
|
1,262,526
|
Market Cap:
|
543.89M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
15.29 - 15.45
|
15.45 - 15.6
|
|
Low:
|
13.4 - 13.54
|
13.54 - 13.68
|
|
Close:
|
14.29 - 14.7
|
14.7 - 15.12
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:33:29 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 17.72 One year: 20.70
|
|
Support:
|
Support1: 13.86 Support2: 13.05
|
|
Resistance:
|
Resistance1:
15.17 Resistance2: 17.72
|
|
Pivot:
|
13.93 
|
|
Moving Averages:
|
MA(5): 14.28 MA(20): 14.05 
MA(100): 14.56 MA(250): 12.99
|
|
MACD:
|
MACD(12,26):
-0.16 Signal(12,26,9): -0.32
|
|
%K %D:
|
%K(14,3): 73.50 %D(3): 60.22
|
|
RSI:
|
RSI(14): 56.46
|
|
52-Week:
|
High: 20.02
Low: 9.10 Change(%): 53.5
|
|
Average Vol(K):
|
3-Month: 230
10-Days 361
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.CTMX has closed above the upper band by 2.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 36.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Tue, 01 Sep 2015 09:09:58 GMT
14.80
Fri, 23 Jun 2017 21:30:07 GMT
CytomX Therapeutics Inc. (CTMX) Moves Higher on Volume Spike for June 23
Mon, 15 May 2017 19:52:30 GMT
CytomX Announces Management Team Changes
Sat, 24 Jun 2017 02:15:00 GMT
Bargain or Bust? What's inside the Numbers For CytomX Therapeutics, Inc ...
Thu, 03 Nov 2016 20:03:45 GMT
CytomX Therapeutics Announces Third Quarter 2016 Financial Results and ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
